Lupin Gets EIR from US FDA for its Somerset Manufacturing Facility
Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset.
Establishment Inspection Report | 24/06/2024 | By Aishwarya | 168
Gland Pharma Receives EIR From USFDA For Dundigal Facility
Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.
Establishment Inspection Report | 25/08/2023 | By Manvi | 478
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy